| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/30/2006 | CN1824656A Methods and compositions utilizing quinazolinones |
| 08/30/2006 | CN1824333A Preparation method of interpose internal radiation anti tumour series medicine |
| 08/30/2006 | CN1824328A Anticancer vaccine and its preparation |
| 08/30/2006 | CN1824325A Human nipple virus DNA inserted vaccine, its preparation method and application |
| 08/30/2006 | CN1824319A Hormone kind anticancer medicine slow release agent |
| 08/30/2006 | CN1824318A Slow release implantation agent for anticancer |
| 08/30/2006 | CN1824317A Compositions for treating tumors containing shark cartilage extracts and anti-neoplastic agents |
| 08/30/2006 | CN1824314A Slow release agent containing hormone kind anti cancer medicine |
| 08/30/2006 | CN1824313A Slow release microsphere containing hormone kind anti cancer medicine and its application |
| 08/30/2006 | CN1824311A Preparation for the prophylaxis of restenosis |
| 08/30/2006 | CN1824308A Therapeutic agent for cachexia |
| 08/30/2006 | CN1824307A Medicinal composition for treating B cell lymph tumour |
| 08/30/2006 | CN1824306A Immunoglobulin-G biofactor chewing gum |
| 08/30/2006 | CN1824300A Application of compound MG 132 in preparation of medicine for treating leucocythemia |
| 08/30/2006 | CN1824299A Application of compound PS-341 in preparation of medicine for treating acute pulp leucocythemia |
| 08/30/2006 | CN1824288A Application of compound PSI in preparation of medicine for treating leucocythemia |
| 08/30/2006 | CN1824184A Medicine for treating lung cancer |
| 08/30/2006 | CN1824180A Traditional Chinese medicine for treating leuhemia |
| 08/30/2006 | CN1824156A Chinese medicine mixed preparation for treating stomach precancer and its preparation method |
| 08/30/2006 | CN1824136A Preparation method of high allicin garlic powder capsule |
| 08/30/2006 | CN1824125A Bee snake capsule and its preparation method |
| 08/30/2006 | CN1824119A Preparation method of compound Chinese medicinal polysaccharide and its use |
| 08/30/2006 | CN1824071A Antiinflammatory toxin resolving capsule and its preparation method |
| 08/30/2006 | CN1823995A New medicine for treating malignant tumour |
| 08/30/2006 | CN1823987A Application of coptic toxin resolving decoction in preparation of medicine for predventing and treating tumour chemotherapy tolerance |
| 08/30/2006 | CN1823985A Pure natural naringin citrus peel orange peel three in one anticancer seasoning capsule pill |
| 08/30/2006 | CN1823917A Cotton leaf ethanol extract, its preparation method and use |
| 08/30/2006 | CN1823916A Extraction method of polygala refined total saponin |
| 08/30/2006 | CN1823904A Compound formula Chinese lobelia vein injection liquid, its preparation method and medicine infusion way |
| 08/30/2006 | CN1823895A Nutritire food for antisenile and anticancer and its manufacturing method |
| 08/30/2006 | CN1823887A Quality control method of injection preparation used for treating tumour |
| 08/30/2006 | CN1823884A Preparation method of aidi injection agent |
| 08/30/2006 | CN1823883A Aidi injection preparation and its preparation method |
| 08/30/2006 | CN1823864A New use of bitter diezi injection liquid |
| 08/30/2006 | CN1823857A Preparation technology of sarcandra extract |
| 08/30/2006 | CN1823848A Potent immunostimulants from microalgae |
| 08/30/2006 | CN1823841A Preparation technology of yellow arsenic nano-particle |
| 08/30/2006 | CN1823812A Formula of stable lentinan infiltration liquid and its preparation method |
| 08/30/2006 | CN1823794A Formulations |
| 08/30/2006 | CN1823788A Application of lucid ganoderma acid in treating cancer as synergistic agent and inhibitor |
| 08/30/2006 | CN1823787A Application of lucid ganoderma acid in preparation of cancer transfer inhibitor |
| 08/30/2006 | CN1823780A Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders |
| 08/30/2006 | CN1823763A Sodium cantharidate drip pill and its preparation method |
| 08/30/2006 | CN1823760A Use of artemisia apiacea kind medicine for treating gliosis |
| 08/30/2006 | CN1823740A Taxadol slow release nano-particle, its preparation method and application |
| 08/30/2006 | CN1823737A Porous drug matrices and methods of manufacture thereof |
| 08/30/2006 | CN1823734A Taxdol self assembled precusor liposome and its preparation method |
| 08/30/2006 | CN1823733A Self asembled precusor liposome containing camptothecin kind medicine and its preparation method |
| 08/30/2006 | CN1823732A Poly olefinic taxadol self assembled precusor liposome and its preparation method |
| 08/30/2006 | CN1823731A Esters of l-carnitine of alkanoyl l-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds |
| 08/30/2006 | CN1823626A Theobromine having carcinogenesis suppressing function |
| 08/30/2006 | CN1272440C Use and constructing method for anticancer recombined gland virus with tumor cell PLK1 as target of medicine |
| 08/30/2006 | CN1272340C Oleanolic acid couple derivatives and their pharmaceutical use |
| 08/30/2006 | CN1272331C Method of extracting three effective components in kudzu vine root |
| 08/30/2006 | CN1272330C Compound 4-methoxy-7-methyl-3-oxo-1,3-dihydro isophenol furan-5-formaldehyde and its preparing method |
| 08/30/2006 | CN1272328C Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 08/30/2006 | CN1272024C Use of dietary additives for preparing medicament for treating malignancies and viral infections and improving immunologic function |
| 08/30/2006 | CN1272014C Enteric soluble preparation of Alun phosphorate and its preparing method |
| 08/30/2006 | CN1271999C Use of extracts and preparations from iris plants and tectorigenin as organ selective medicament for treating urethra disease |
| 08/30/2006 | CN1271992C Cationic virosomes as transfer system for genetic material |
| 08/29/2006 | USRE39251 E.g., 7,11-Di(hydroxy)-8,8,10,12,16-pentamethyl-3-(1-methyl-2-(methylthiazol-4-yl)ethenyl)-4-aza-17-oxabicyclo(14.1.0)heptadecane-5,9-dione, preferably Form A; anticarcinogenic, -proliferative, -diabetic, -inflammatory agents; viricides; autoimmune diseases; psoriasis; agents; cardiovascular disorders |
| 08/29/2006 | US7098343 Polycyclic compounds containing a central trivalent atom to which is attached either direct or indirectly via a linker a two or three ring system and a ring system contining sulphamate group as substituent; steroid sulfatase inhibitor |
| 08/29/2006 | US7098336 FXR NR1H4 nuclear receptor binding compounds |
| 08/29/2006 | US7098334 Inhibitors of 5'-methylthioadenosine phosphorylase (MTAP) and 5'-methylthioadenosine nucleosidase (MTAN); treating cancer, malaria, bacterial infections; (1S)-1-(9-deazaadenin-9-yl)-1,4,5-trideoxy-1,4-imino-D-ribitol for example |
| 08/29/2006 | US7098332 5,8-Dihydro-6H-pyrido[2,3-d]pyrimidin-7-ones |
| 08/29/2006 | US7098330 Pyrazolylamine substituted quinazoline compounds useful as protein kinase inhibitors |
| 08/29/2006 | US7098322 Tumor necrosis factor and proteins with amino acid sequences to modulate signal passageways |
| 08/29/2006 | US7098316 Isolated nucleic acid, coding regions of genes of proteins, vectors, host cells and genetic engineering for producing proteins and diagnosis of diseaes |
| 08/29/2006 | US7098311 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of cell proliferative disorders |
| 08/29/2006 | US7098308 Pentapeptide compounds and uses related thereto |
| 08/29/2006 | US7098247 Arylene-carboxylic acid (2-amino-phenyl)-amide derivatives |
| 08/29/2006 | US7098241 Thiophene hydroxamic acid derivatives |
| 08/29/2006 | US7098239 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 08/29/2006 | US7098236 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 08/29/2006 | US7098218 7,8,9, or 10-sulfamyl, (thio)phosphonyl, sulfonyl, or sulfonamido-naphth[2,1-f]isoquinolin-1,3-diones; drug screening; enzyme inhibitors; anticarcinogenic agents |
| 08/29/2006 | US7098212 Piperazine derivatives |
| 08/29/2006 | US7098209 Phosphodiesterase inhibitors; cardiovascular disorders; erectile dysfunction; hypotensive agents; respiratory system diosrders; chronic obstructive pulmonary disease; congestive heart failure; antihistamines; antiallergens |
| 08/29/2006 | US7098204 Hymenialdisine or derivatives thereof in the manufacture of medicaments |
| 08/29/2006 | US7098197 An antiviral nucleoside in which the 5'-hydroxyl group has been substituted for a phosphonate or methyl phosphonate that is covalently linked to an alkylethanediol; osteoporosis; anticarcinogenic agents; viricides |
| 08/29/2006 | US7098192 Antisense oligonucleotide modulation of STAT3 expression |
| 08/29/2006 | US7098186 Depsipeptide compound |
| 08/29/2006 | US7098024 Depsipeptide compound |
| 08/29/2006 | US7098012 DNA demethylase, therapeutic and diagnostic uses thereof |
| 08/29/2006 | US7098004 Isolated polypeptide of the stratum corneum and its use |
| 08/29/2006 | US7097994 UDP-N-acetylglucosamine:galactose-β1,3-N-acetylgalactosamine-α-R/ (GlcNAc to GaINAc) β1-6 N-acetylglucosaminyltransferase, C2GnT3 |
| 08/29/2006 | US7097986 For use in pharmaceutical and diagnostic formulations |
| 08/29/2006 | US7097985 for the treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, wound healing and psoriasis |
| 08/29/2006 | US7097977 Target of anticancer agent |
| 08/29/2006 | US7097823 Administering a RADIONUCLIDE COMPLEXED WITH A CHELATING AGENT SUCH AS MACROCYCLIC AMINOPHOSPHONIC ACID, or tetraazacyclododecanetetramethylenephosphonic acid (DOTMP); osteomyelitis treatment |
| 08/29/2006 | CA2402020C Pharmaceutical compositions |
| 08/29/2006 | CA2392271C Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents |
| 08/29/2006 | CA2280905C Highly lipophilic camptothecin derivatives |
| 08/29/2006 | CA2255615C Compositions comprising conjugates of cis-docosahexaenoic acid and docetaxel |
| 08/29/2006 | CA2212856C Benzopyran-containing compounds and method for their use |
| 08/29/2006 | CA2112779C Arylsulfonamido-substituted hydroxamic acids |
| 08/29/2006 | CA2053585C Antibody production in chinese hamster ovary cells |
| 08/24/2006 | WO2006089290A1 Combinations and modes of administration of therapeutic agents and combination therapy |
| 08/24/2006 | WO2006089251A2 SYNERGISTIC EFFECT OF TGF-β BLOCKADE AND IMMUNOGENIC AGENTS ON TUMORS |
| 08/24/2006 | WO2006089231A2 Monoclonal antibodies against prostate specific membrane antigen (psma) lacking in fucosyl residues |
| 08/24/2006 | WO2006089177A2 Isoxazole combretastin derivatives for the treatment of disorders |